let me simplify this for all those who think a CR is bad.
If your drug candidate is a dog - CR is bad.
If your drug candidate has the makings of a being a success in a boring indication - meh.
if your drug candidate has the makings of being a success in indications involving fibrosis - a CR will allow instos who want to ride the history of success in and boom!
I am going with the last one.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $92.76M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.9¢ | 5.7¢ | $67.63K | 1.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 261071 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 360185 | 2 |
View Market Depth
| Last trade - 15.59pm 07/08/2025 (20 minute delay) ? |
| SNT (ASX) Chart |